CLINICAL TRIALS PROFILE FOR EDIVOXETINE

Clinical Trials for Edivoxetine

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00420004 ↗	A Study for Participants With Major Depression	Completed	Eli Lilly and Company	Phase 2	This is a study to assess the safety and effectiveness of LY2216684 compared to placebo in treating adults with major depressive disorder.
NCT00922636 ↗	A Study of Pediatric Patients With Attention Deficit/Hyperactivity Disorder	Completed	Eli Lilly and Company	Phase 2/Phase 3	The primary purpose of your child's participation in this study is to determine whether LY2216684 can help pediatric patients with attention-deficit/hyperactivity disorder (ADHD); and assess the safety of LY2216684 and any side effects that might be associated with it.
NCT00965419 ↗	A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder	Terminated	Eli Lilly and Company	Phase 2/Phase 3	The primary purpose of the study is to assess long-term safety and tolerability of Edivoxetine in pediatric participants with attention deficit hyperactive disorder (ADHD).
NCT01155661 ↗	A Safety Study in Participants With Major Depressive Disorder	Completed	Eli Lilly and Company	Phase 3	The primary objective of this study is to evaluate the long-term safety and tolerability of LY2216684 administered once daily (QD) in the adjunctive treatment with a selective serotonin reuptake inhibitor (SSRI) for up to approximately 1 year in participants with major depressive disorder (MDD) who are partial responders to their SSRI treatment.

Clinical Trial Conditions for Edivoxetine

Condition Name

Condition Name for
Intervention	Trials
Major Depressive Disorder	6
Attention Deficit Hyperactivity Disorder	2
Depressive Disorder, Major	2
Major Depressive Disorder (MDD)	1

Condition MeSH

Condition MeSH for
Intervention	Trials
Depressive Disorder, Major	9
Depressive Disorder	9
Depression	9
Disease	7

Clinical Trial Locations for Edivoxetine

Trials by Country

Trials by Country for
Location	Trials
United States	103
Puerto Rico	4
United Kingdom	3
Japan	3
Germany	2

Trials by US State

Trials by US State for
Location	Trials
Florida	9
Pennsylvania	8
Texas	7
California	7
Indiana	6

Clinical Trial Progress for Edivoxetine

Clinical Trial Phase

Clinical Trial Phase for
Clinical Trial Phase	Trials
Phase 3	6
Phase 2/Phase 3	2
Phase 2	1

Clinical Trial Status

Clinical Trial Status for
Clinical Trial Phase	Trials
Completed	10
Terminated	1

Clinical Trial Sponsors for Edivoxetine

Sponsor Name

Sponsor Name for
Sponsor	Trials
Eli Lilly and Company	11

Sponsor Type

Sponsor Type for
Sponsor	Trials
Industry	11